High cholesterol doesn't cause heart disease. Inflammation does. Here's the difference.
You get your annual labs back. Your total cholesterol is 240. Your doctor reaches for the prescription pad. Sound familiar? This scenario plays out millions of times a year, and it's built on an incomplete understanding of cardiovascular risk that's decades overdue for an update.
This isn't anti-statin propaganda. Statins save lives in specific populations. But the idea that total cholesterol or even standard LDL numbers are the primary drivers of heart disease has been quietly dismantled by the research over the past 20 years — and most annual physicals haven't caught up.
The Particle Size Problem
When your lab report says "LDL: 130 mg/dL," it's telling you the amount of cholesterol carried by LDL particles. What it doesn't tell you is the number or size of those particles — and that distinction is everything.
- Pattern A (large, buoyant LDL) — These particles are like beach balls floating through your bloodstream. They're too large to penetrate the arterial wall easily. People with predominantly large LDL particles have significantly lower cardiovascular risk, even with higher LDL numbers.
- Pattern B (small, dense LDL) — These are like BBs. They slip into the arterial lining, get oxidized, and trigger the inflammatory cascade that actually builds plaque. This is the pattern that matters.
Two people can have identical LDL of 140 mg/dL. One has mostly large particles and minimal risk. The other has small, dense particles and is building plaque right now. Standard lipid panels can't tell the difference.
Testing That Actually Matters
Advanced lipid testing like the NMR LipoProfile or the Cleveland HeartLab panel measures LDL particle number (LDL-P) and size distribution. An LDL-P above 1,000 nmol/L is a far stronger predictor of cardiovascular events than standard LDL-C. If you're going to make treatment decisions, make them on better data.
The Triglyceride-to-HDL Ratio: Your Best Free Metric
If you want a single number from a standard lipid panel that actually predicts cardiovascular and metabolic risk, it's the triglyceride-to-HDL ratio. Divide your triglycerides by your HDL. That's it.
- Ratio under 2:1 — Associated with predominantly large, buoyant LDL particles. Lower cardiovascular risk.
- Ratio over 3:1 — Strongly associated with small, dense LDL, insulin resistance, and metabolic syndrome. This is where real risk lives.
A person with total cholesterol of 260, triglycerides of 70, and HDL of 75 (ratio: 0.93) is almost certainly metabolically healthier than someone with total cholesterol of 190, triglycerides of 200, and HDL of 38 (ratio: 5.26). The first person might get a lecture from their doctor. The second might get told they're fine. That's a problem.
Inflammation: The Actual Driver
Cholesterol doesn't spontaneously jump into your arteries and form plaque. The process requires damage to the arterial lining, followed by an inflammatory response, followed by oxidized LDL particles being engulfed by macrophages to form foam cells. No inflammation, no plaque — regardless of cholesterol levels.
Key inflammatory markers that belong in every cardiovascular assessment:
- hs-CRP (high-sensitivity C-reactive protein) — A marker of systemic inflammation. The JUPITER trial showed that people with elevated hs-CRP had increased cardiac events even with normal cholesterol. Values above 2.0 mg/L signal elevated risk.
- Lp(a) (lipoprotein little a) — A genetically determined particle that's both pro-thrombotic and pro-inflammatory. Elevated in roughly 20% of the population, and it's barely tested. If you have a family history of early heart disease, demand this test.
- Homocysteine — Elevated levels damage the endothelial lining directly. Often correctable with methylated B vitamins (B12, folate, B6).
- Oxidized LDL — The form of LDL that actually drives plaque formation. Standard panels don't measure it.
Why Statins Aren't Always the Answer
Let's be clear: statins have a well-established role in secondary prevention — meaning people who've already had a heart attack or stroke. In that population, the data is strong and the benefit is meaningful.
For primary prevention (people who've never had an event), the picture is murkier. The absolute risk reduction is often small — on the order of 1–2% over 5 years in many trials. Meanwhile, statins carry real side effects:
- Muscle pain and weakness (reported in 10–29% of users depending on the study)
- Increased risk of type 2 diabetes (established in multiple meta-analyses)
- CoQ10 depletion (statins block the same pathway that produces CoQ10)
- Cognitive complaints (acknowledged by the FDA in 2012 label updates)
None of this means statins are bad. It means the decision to take one should be based on comprehensive risk assessment, not a reflexive response to a total cholesterol number.
What Actually Reduces Cardiovascular Risk
Whether or not you take a statin, the following interventions address the root drivers of cardiovascular disease:
- Fix insulin resistance. Metabolic dysfunction is the engine behind small dense LDL, high triglycerides, low HDL, and chronic inflammation. Address it with dietary changes (reduce refined carbohydrates and seed oils), strength training, and sleep optimization.
- Reduce inflammatory triggers. Processed food, excess omega-6 fatty acids, chronic stress, poor sleep, and visceral fat all drive the inflammation that makes cholesterol dangerous.
- Optimize omega-3 intake. EPA and DHA reduce triglycerides, lower inflammation, and stabilize arterial plaque. Aim for 2–4 grams of combined EPA/DHA daily from wild-caught fish or high-quality fish oil.
- Support methylation. Keep homocysteine in check with methylated B12, methylfolate, and B6. This is especially important for people with MTHFR variants.
- Exercise consistently. Both aerobic exercise and resistance training improve lipid profiles, insulin sensitivity, and endothelial function. This is the closest thing to a cardiovascular cure-all that exists.
The Bottom Line
Your total cholesterol number is a blunt instrument. It's like judging a city's crime rate by counting the total number of people who live there. Context matters. Particle size matters. Inflammation matters. Metabolic health matters.
Get advanced lipid testing. Check your inflammatory markers. Calculate your triglyceride-to-HDL ratio. And make treatment decisions based on the full picture — not a single number on a standard panel that hasn't evolved in 40 years.